Viewing Study NCT04011293


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-24 @ 1:16 AM
Study NCT ID: NCT04011293
Status: UNKNOWN
Last Update Posted: 2019-07-08
First Post: 2019-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
Sponsor: Shandong University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed or Refractory Hematological Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Refractory View
None Malignancy View